Clinical Trials Study
Copyright ©The Author(s) 2015.
World J Gastroenterol. Apr 21, 2015; 21(15): 4652-4659
Published online Apr 21, 2015. doi: 10.3748/wjg.v21.i15.4652
Figure 1
Figure 1 Survival analysis based on adherence to flupentixol-melitracen treatment among patients with functional dyspepsia. The survival analysis was calculated as the number of patients who remained therapy-compliant for each day of the study. Group 1 exhibited a significantly higher compliance rate than did those in Groups 2 and 3 (Group 1 vs Group 2, P = 0.002; Group 1 vs Group 3, P = 0.018).